EP
ONC

Elkfork Partners’s BeOne Medicines Ltd ONC Stock Holding History

Elkfork Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$48K Hold
392
– – ﹤0.01% 988
2019
Q2 		$49K Buy
392
+56
+17% +$7.11K ﹤0.01% 998
2019
Q1 		$44K Hold
336
– – ﹤0.01% 988
2018
Q4 		$47K Buy
+336
New +$44.6K ﹤0.01% 950

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Elkfork Partners's ONC Position: Q3 2019 in Review

Elkfork Partners held its BeOne Medicines Ltd (ONC) position steady in Q3 2019 at 392 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Elkfork Partners first reported a position in ONC in Q4 2018 and has held it in 4 quarters since. The position peaked at $49K in Q2 2019. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

  • Elkfork Partners held 392 shares of BeOne Medicines Ltd worth $48K as of Q3 2019.
  • Elkfork Partners left its BeOne Medicines Ltd share count unchanged in Q3 2019.
  • BeOne Medicines Ltd made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #988 holding.
  • Elkfork Partners first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 4 quarters since.
  • Elkfork Partners's BeOne Medicines Ltd position peaked at $49K in Q2 2019.
  • 196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.